New York Assembly bill in Session 2025-2026.
Status: in_committee. Latest action: January 7, 2026.
Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology.
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
| Date | Event | Detail |
|---|---|---|
| 2025-04-11 | Introduced | Bill introduced |
| 2026-01-07 | Status | in_committee |
| 2026-01-07 | Latest Action | In Assembly Committee |